John Xue
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
-
- DNA Repair Mechanisms
- Cell death mechanisms and regulation
- Cancer therapeutics and mechanisms
- Ubiquitin and proteasome pathways
- RNA Interference and Gene Delivery
Papers in
-
- DNA Repair Mechanisms 6
- Cancer therapeutics and mechanisms 4
- Cell death mechanisms and regulation 4
-
- Microtubule and mitosis dynamics 5
- Co-authors
- Zhan Xiao (6 shared papers)Thomas J. Sowin (6 shared papers)Haiying Zhang (5 shared papers)Saul H. Rosenberg (4 shared papers)Haichao Zhang (6 shared papers)Gaoquan Li (2 shared papers)Zhi‐Fu Tao (2 shared papers)Mai H. Bui (2 shared papers)
- Journals
- International Journal of Cancer (2 papers)Cancer Research (2 papers)Blood (2 papers)Molecular Cancer Therapeutics (1 paper)Biomarkers (1 paper)
- Partner nations
- United StatesSouth Africa
In The Last Decade
John Xue
12 papers receiving 410 citations
Peers
Comparison fields: 5 of 58
- Oncology 240
- Molecular Biology 352
- Cancer Research 67
- Cell Biology 57
- Toxicology 7
Countries citing papers authored by John Xue
This map shows the geographic impact of John Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Xue more than expected).
Fields of papers citing papers by John Xue
This network shows the impact of papers produced by John Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Xue. The network helps show where John Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside John Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 103 | |
| 2 | 2006 | 77 | |
| 3 | 2004 | 73 | |
| 4 | 2015 | 43 | |
| 5 | 2005 | 36 | |
| 6 | 2021 | 32 | |
| 7 | 2008 | 20 | |
| 8 | 2015 | 11 | |
| 9 | 2008 | 10 | |
| 10 | 2017 | 8 | |
| 11 | 2014 | 3 | |
| 12 | 2014 | 1 | |
| 13 | 2022 | 0 |
About John Xue
John Xue is a scholar working on Molecular Biology, Cell Biology, Oncology, Pathology and Forensic Medicine and Discrete Mathematics and Combinatorics, having authored 13 papers that have together received 417 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (6 papers), Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (4 papers), Cancer therapeutics and mechanisms (4 papers), Cell death mechanisms and regulation (4 papers), Lymphoma Diagnosis and Treatment (1 paper), Genetic factors in colorectal cancer (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Oncology (240 citations), Molecular Biology (352 citations), Cancer Research (67 citations), Cell Biology (57 citations) and Toxicology (7 citations). John Xue has collaborated with scholars based in United States and South Africa. Frequent co-authors include Zhan Xiao, Thomas J. Sowin, Haiying Zhang, Saul H. Rosenberg, Haichao Zhang, Gaoquan Li, Zhi‐Fu Tao, Mai H. Bui, Wen‐Zhen Gu and Nan‐Horng Lin. Their work appears in journals such as International Journal of Cancer, Cancer Research, Blood, Molecular Cancer Therapeutics and Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.